NPR : World Cafe

Filed Under:

Loudon Wainwright III On World Cafe

Loudon Wainwright III has the makings of a great legacy many times over. His children — including Rufus and Martha — are successful musicians in their own right, and Wainwright's body of work has obviously influenced them. Though he's developed a diverse repertoire of songs, movies, plays and dialogues, Wainwright has focused largely on music since he saw Bob Dylan play the famous Newport Folk Festival in 1962.

Wainwright wrote his first song after being inspired by an old lobsterman named Edgar in a Rhode Island boatyard, and since then, he's recorded more than 20 albums. His witty, self-deprecating style — mixed with a current of easily understood sentimentality — has attracted a large fan base. Wainwright's latest album is a meditation on life, death and family; appropriately, it's a family affair. The title, Older Than My Old Man Now, references his late father, and the record features each of Wainwright's children.

Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.

NPR

A Personal History Of L.A. Punk: 'It Was A Free-For-All For Outcasts'

John Doe, Exene Cervenka and Dave Alvin of X join Fresh Air to discuss punk's early days. "Anybody could belong to punk that wanted to be there," Cervenka says. "[It] didn't matter how old you were."
NPR

'Touch Tours' Help Blind Experience Philadelphia's Historic Food Scene

A hands-on tour of Philadelphia's historic Italian Market includes time to appreciate the scents and sounds — and opportunities to sample the district's delicious chocolate, cheeses and fresh pastas.
NPR

WATCH: Ted Cruz Clashes With Trump Supporter, 'He Is Playing You For A Chump'

It wasn't the only unfortunate incident that befell Ted Cruz's campaign over the weekend as he's struggling to catch Donald Trump ahead of Tuesday's crucial vote.
NPR

Biotech's Theranos Offers A Cautionary Tale For Silicon Valley

The blood-testing startup led by Elizabeth Holmes soared on hype and celebrity boosters. Now it's under federal scrutiny. It could show that Silicon Valley's success model doesn't work in biotech.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.